Presentations included a case study of the workflow for building multispecifics and the launch of OmniHub™, a bioinformatics tools platform...
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of November...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of September. H.C...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial...
単一ドメイン抗体(sdAb)を産生する遺伝子改変ニワトリが、完全ヒト型安定化sdAbを産生する2023年発表の新規トランス...
Engineered chickens producing single domain antibodies (sdAbs) provided the scientific foundation for...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June...
Technical synergies between xPloration, OmniFlic®, OmniClic® and OmniDeep® enable new bispecific antibody...
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May. RBC...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads